| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; loading ...; fig 5c
| Qi J, Li T, Bian H, Li F, Ju Y, Gao S, et al. SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis. FEBS Open Bio. 2016;6:326-37 pubmed publisher |
- western blot; human; 1:1000; fig 3
| Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, et al. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. J Hematol Oncol. 2015;8:120 pubmed publisher |
- immunocytochemistry; human
| Hsueh Y, Chen H, Wu S, Wang T, Chen J, Ma D. Lysophosphatidic acid induces YAP-promoted proliferation of human corneal endothelial cells via PI3K and ROCK pathways. Mol Ther Methods Clin Dev. 2015;2:15014 pubmed publisher |
- western blot; mouse; 1:750
| Domitrovic R, Cvijanovic O, Susnić V, Katalinić N. Renoprotective mechanisms of chlorogenic acid in cisplatin-induced kidney injury. Toxicology. 2014;324:98-107 pubmed publisher |
| Nicholas C, Yang J, Peters S, Bill M, Baiocchi R, Yan F, et al. PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.). PLoS ONE. 2013;8:e74710 pubmed publisher |
- immunohistochemistry; mouse; 1:1000
| Garcia T, Hofmann M. NOTCH signaling in Sertoli cells regulates gonocyte fate. Cell Cycle. 2013;12:2538-45 pubmed publisher |
- western blot; mouse; 1:1000
| Durieux A, Vassilopoulos S, Laine J, Fraysse B, Brinas L, Prudhon B, et al. A centronuclear myopathy--dynamin 2 mutation impairs autophagy in mice. Traffic. 2012;13:869-79 pubmed publisher |
| Xie X, Jiang Y, Yuan Y, Wang P, Li X, Chen F, et al. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis. Oncotarget. 2016;7:59987-60004 pubmed publisher |
| Gong X, Wang Y, Zeng J, Li S, Luo Y. Computational identification and experimental validation of microRNAs binding to the fragile X syndrome gene Fmr1. Neurochem Res. 2015;40:109-17 pubmed publisher |
| Qu D, Xu H, Han X, Wang Y, Ouyang C. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance. Eur Rev Med Pharmacol Sci. 2014;18:516-9 pubmed |
| Jin T, Fu J, Feng X, Wang S, Huang X, Zhu M, et al. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth. Cell Biol Int. 2013;37:929-39 pubmed publisher |
| Yan Z, Bao Z, Yan W, Liu Y, Zhang C, Wang H, et al. Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype. Curr Mol Med. 2013;13:438-45 pubmed |
| Du N, Feng J, Hu L, Sun X, Sun H, Zhao Y, et al. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol Rep. 2012;27:1893-903 pubmed publisher |
| Yue X, Zhang Z, Liang X, Gao L, Zhang X, Zhao D, et al. Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E. Gastroenterology. 2012;142:1559-70.e2 pubmed publisher |
| Zhang S, Qian Y, Liu A, Cai J, Zhao X, Wei J, et al. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma. Hum Pathol. 2012;43:1084-93 pubmed publisher |
| Wei W, Chua M, Grepper S, So S. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol Cancer. 2011;10:16 pubmed publisher |
| Ottewell P, Woodward J, Lefley D, Evans C, Coleman R, Holen I. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol Cancer Ther. 2009;8:2821-32 pubmed publisher |
| Stefancikova L, Moulis M, Fabian P, Falkova I, Vasova I, Kren L, et al. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected. J Clin Pathol. 2009;62:948-50 pubmed publisher |
| Wei W, Chua M, Grepper S, So S. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. Mol Cancer. 2009;8:76 pubmed publisher |
| Weinberger P, Merkley M, Lee J, Adam B, Gourin C, Podolsky R, et al. Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites. Arch Otolaryngol Head Neck Surg. 2009;135:694-703 pubmed publisher |
| Bimpaki E, Nesterova M, Stratakis C. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur J Endocrinol. 2009;161:153-61 pubmed publisher |
| Chen K, Sacks P, Spratt T, Lin J, Boyiri T, Schwartz J, et al. Modulations of benzo[a]pyrene-induced DNA adduct, cyclin D1 and PCNA in oral tissue by 1,4-phenylenebis(methylene)selenocyanate. Biochem Biophys Res Commun. 2009;383:151-5 pubmed publisher |
| Psyrri A, Egleston B, Weinberger P, Yu Z, Kowalski D, Sasaki C, et al. Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray. Cancer Epidemiol Biomarkers Prev. 2008;17:1486-92 pubmed publisher |
| Yu Z, Weinberger P, Provost E, Haffty B, Sasaki C, Joe J, et al. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Clin Cancer Res. 2005;11:2471-7 pubmed |
| Pohl G, Ho C, Kurman R, Bristow R, Wang T, Shih I. Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. Cancer Res. 2005;65:1994-2000 pubmed |
| Yu Z, Weinberger P, Haffty B, Sasaki C, Zerillo C, Joe J, et al. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2005;11:1160-6 pubmed |
